Home
Information
European Medicines Agency Orphan Drug Status
Summary of Product Characteristics (SPC)
Technology
Clinical Development
Publications & Scientific Papers
Review Articles
Clinical Publications
Pre-Clinical Publications
Tools & Forms
Patient Informed Concent
Contact
Review Articles
Title
Date
Lipoplatin Formulation Review Article
2011
Lipoplatin Treatment in Lung and Breast Cancer
2011
Diagnostic and Therapeutic Efficacy of Imaging Modalities in Non-Small Cell Lung Cancer (NSCLC): experience from a Phase III clinical study using tumor targeted Lipoplatin nanoparticles
2008
Designing platinum compounds in cancer: structures and mechanisms
2007
Liposomal cisplatin: Lipoplatin
2007
Molecular mechanisms of cisplatin and its liposomally encapsulated form, LipoplatinTM. LipoplatinTM as a chemotherapy and antiangiogenesis drug
2007
Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (Review)
2004
Cisplatin and platinum drugs at the molecular level (Review)
2003
© 2018 Regulon Group - Lipoplatin is a licensed product of
Regulon Inc.
